-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Evolutionary Genomics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Evolutionary Genomics, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$412K, a 38.3% increase year-over-year.
- Evolutionary Genomics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$2.01M, a 30% increase year-over-year.
- Evolutionary Genomics, Inc. annual Operating Income (Loss) for 2022 was -$2.01M, a 30% increase from 2021.
- Evolutionary Genomics, Inc. annual Operating Income (Loss) for 2021 was -$2.88M, a 0.06% increase from 2020.
- Evolutionary Genomics, Inc. annual Operating Income (Loss) for 2020 was -$2.88M, a 272% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)